Novel regulatory program for norepinephrine-induced epithelial-mesenchymal transition in gastric adenocarcinoma cell lines

Cancer Science

Volumn 105, Issue 7, 2014, Pages 847-856

  Shan, Tao ^a   Cui, Xijuan ^a   Li, Wei ^b   Lin, Wanrun ^c   Li, Yiming ^a   Chen, Xi ^a   Wu, Tao ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

EMT; Gastric adenocarcinoma; HIF 1 ; Norepinephrine

Indexed keywords

NORADRENALIN; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; VIMENTIN;

ARTICLE; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; EPITHELIUM CELL; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA;

EMT; GASTRIC ADENOCARCINOMA; HIF-1Α; NOREPINEPHRINE; Β2-AR;

ADENOCARCINOMA; BIOLOGICAL MARKERS; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, BETA-2; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; VIMENTIN;

EID: 84904278848     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12438     Document Type: Article

References (35)

1. Amin S, Lucas AL, Frucht H. Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis. Pancreas 2012; 42: 249-53.
2. Moussas GI, Papadopoulou AG, Christodoulaki AG, Karkanias AP. Psychological and psychiatric problems in cancer patients: relationship to the localization of the disease. Psychiatrike 2012; 23: 46-60.
3. Ng BHP, Tsang HWH. Psychophysiological outcomes of health qigong for chronic conditions: a systematic review. Psychophysiology 2009; 46: 257-69.
4. Bulli F, Miccinesi G, Maruelli A, Katz M, Paci E. The measure of psychological distress in cancer patients: the use of distress thermometer in the oncological rehabilitation center of florence. Support Care Cancer 2009; 17: 771-9.
5. Taylor CB, Conrad A, Wilhelm FH et al. Psychophysiological and cortisol responses to psychological stress in depressed and nondepressed older men and women with elevated cardiovascular disease risk. Psychosom Med 2006; 68: 538-46.
6. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry 2003; 54: 269-82.
7. Spiegel D, Sephton SE. Psychoneuroimmune and endocrine pathways in cancer: effects of stress and support. Semin Clin Neuropsychiatry 2001; 6: 252-65.
8. Lin X, Luo K, Lv Z, Huang J. Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice. Hepatogastroenterology 2012; 59: 584-8.
9. Shah SM, Carey IM, Owen CG, Harris T, Dewilde S, Cook DG. Does beta-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study. Br J Clin Pharmacol 2011; 72: 157-61.
10. Liao X, Che X, Zhao W, Zhang D, Bi T, Wang G. The beta-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor kappaB signaling. Oncol Rep 2010; 24: 1669-76.
11. Slotkin TA, Zhang JA, Dancel R, Garcia SJ, Willis C, Seidler FJ. beta-adrenoceptor signaling and its control of cell replication in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat 2000; 60: 153-66.
12. Fitzgerald PJ. Is norepinephrine an etiological factor in some types of cancer? Int J Cancer 2009; 124: 257-63.
13. Thaker PH, Han LY, Kamat AA et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 2006; 12: 939-44.
14. Hu HT, Ma QY, Zhang D et al. HIF-1 alpha links beta-adrenoceptor agonists and pancreatic cancer cells under normoxic condition. Acta Pharmacol Sin 2010; 31: 102-10.
15. Jiang J, Tang YL, Liang XH. EMT: a new vision of hypoxia promoting cancer progression. Cancer Biol Ther 2011; 11: 714-23.
16. Ksiazkiewicz M, Markiewicz A, Zaczek AJ. Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells. Pathobiology 2012; 79: 195-208.
17. Tiwari N, Gheldof A, Tatari M, Christofori G. EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol 2012; 22: 194-207.
18. Heldin CH, Vanlandewijck M, Moustakas A. Regulation of EMT by TGFbeta in cancer. FEBS Lett 2012; 586: 1959-70.
19. Foroni C, Broggini M, Generali D, Damia G. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. Cancer Treat Rev 2012; 38: 689-97.
20. Guo K, Ma Q, Wang L et al. Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol. Oncol Rep 2009; 22: 825-30.
21. Lemogne C, Consoli SM. Depression and cancer: challenging the myth through epidemiology. Psycho-oncologie 2010; 4: 22-7.
22. Durdux C. Depression and cancer: the point of view of the oncologist. Psycho-oncologie 2010; 4: 36-41.
23. Bastid J. EMT in carcinoma progression and dissemination: facts, unanswered questions, and clinical considerations. Cancer Metastasis Rev 2012; 31: 277-83.
24. Krantz SB, Shields MA, Dangi-Garimella S, Munshi HG, Bentrem DJ. Contribution of epithelial-to-mesenchymal transition and cancer stem cells to pancreatic cancer progression. J Surg Res 2012; 173: 105-12.
25. Zhao R, Wu Z, Zhou Q. Epithelial-mesenchymal transition and tumor metastasis. Zhongguo Fei Ai Za Zhi 2011; 14: 620-4.
26. Gomes LR, Terra LF, Sogayar MC, Labriola L. Epithelial-mesenchymal transition: implications in cancer progression and metastasis. Curr Pharm Biotechnol 2011; 12: 1881-90.
27. Yoo YG, Christensen J, Huang LE. HIF-1alpha confers aggressive malignant traits on human tumor cells independent of its canonical transcriptional function. Cancer Res 2011; 71: 1244-52.
28. Shin HW, Cho K, Kim DW et al. Hypoxia-inducible factor 1 mediates nasal polypogenesis by inducing epithelial-to-mesenchymal transition. Am J Respir Crit Care Med 2012; 185: 944-54.
29. Hung JJ, Yang MH, Hsu HS, Hsu WH, Liu JS, Wu KJ. Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer. Thorax 2009; 64: 1082-9.
30. Stefania C, Erica N, Alessandra C et al. Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis 2008; 29: 2267-78.
31. Haase VH. Oxygen regulates epithelial-to-mesenchymal transition: insights into molecular mechanisms and relevance to disease. Kidney Int 2009; 76: 492-9.
32. Zhao JH, Luo Y, Jiang YG, He DL, Wu CT. Knockdown of beta-Catenin through shRNA cause a reversal of EMT and metastatic phenotypes induced by HIF-1alpha. Cancer Invest 2011; 29: 377-82.
33. David JM, Rajasekaran AK. Dishonorable discharge: the oncogenic roles of cleaved E-cadherin fragments. Cancer Res 2012; 72: 2917-23.
34. Vered M, Allon I, Buchner A, Dayan D. E-cadherin in oral SCC: an analysis of the confusing literature and new insights related to its immunohistochemical expression. Histol Histopathol 2012; 27: 141-50.
35. Lian N, Lin T, Liu W et al. TGFbeta suppresses osteoblast differentiation via the vimentin-activating transcription factor 4 (atf4) axis. J Biol Chem 2012; 287: 35975-84.